Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
Westwood Holdings Group
WHG
$182M
| $10.7M | 0.01% |
679,558
+10,342
| +2% | +$197K |
2013 Q2
28 quarters
|
|
1177
Voyager Therapeutics
VYGR
$141M
| $10.7M | 0.01% |
845,680
-197,121
| -19% | -$2.29M |
2018 Q1
9 quarters
|
|
|
GSS
1178
DELISTED
Golden Star Resources Ltd.
GSS
| $10.7M | 0.01% |
3,675,028
+1,614,290
| +78% | +$4.19M |
2013 Q2
28 quarters
|
|
1179
Rigel Pharmaceuticals
RIGL
$913M
| $10.6M | 0.01% |
581,768
+160,856
| +38% | +$2.89M |
2019 Q1
5 quarters
|
|
1180
Mesa Laboratories
MLAB
$713M
| $10.6M | 0.01% |
49,100
+15,200
| +45% | +$3.5M |
2013 Q2
28 quarters
|
|
1181
DELISTED
Sealed Air
SEE
| $10.6M | 0.01% |
323,909
-22,500
| -6% | -$676K |
2018 Q4
6 quarters
|
|
|
FPRX
1182
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $10.6M | 0.01% |
1,744,048
-227,869
| -12% | -$939K |
2018 Q1
9 quarters
|
|
1183
HUB Group
HUBG
$1.63B
| $10.6M | 0.01% |
+444,272
| New | +$10.3M |
2020 Q2
0 quarters
|
|
1184
World Acceptance Corp
WRLD
$824M
| $10.6M | 0.01% |
161,925
-53,375
| -25% | -$3.34M |
2017 Q3
11 quarters
|
|
|
ANH
1185
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $10.6M | 0.01% |
6,234,590
-670,300
| -10% | -$1.04M |
2014 Q2
24 quarters
|
|
|
LCI
1186
DELISTED
Lannett Company, Inc.
LCI
| $10.6M | 0.01% |
364,784
+93,175
| +34% | +$2.9M |
2019 Q2
4 quarters
|
|
1187
DELISTED
Golden Ocean Group
GOGL
| $10.6M | 0.01% |
2,720,769
-980,832
| -26% | -$3.44M |
2016 Q1
17 quarters
|
|
1188
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$50.8B
| $10.5M | 0.01% |
115,150
+28,000
| +32% | +$2.56M |
2017 Q4
10 quarters
|
|
|
NATI
1189
DELISTED
National Instruments Corp
NATI
| $10.5M | 0.01% |
271,866
-46,800
| -15% | -$1.77M |
2019 Q4
2 quarters
|
|
1190
Highwoods Properties
HIW
$3.26B
| $10.5M | 0.01% |
281,700
-729,402
| -72% | -$27.1M |
2016 Q4
14 quarters
|
|
1191
Star Bulk Carriers
SBLK
$3.46B
| $10.5M | 0.01% |
1,591,826
-219,200
| -12% | -$1.26M |
2016 Q3
15 quarters
|
|
1192
CACI
CACI
$13.5B
| $10.5M | 0.01% |
48,400
-3,200
| -6% | -$765K |
2019 Q2
4 quarters
|
|
1193
Texas Capital Bancshares
TCBI
$3.93B
| $10.5M | 0.01% |
339,900
+35,600
| +12% | +$997K |
2018 Q1
9 quarters
|
|
1194
Repay Holdings
RPAY
$319M
| $10.5M | 0.01% |
+425,200
| New | +$8.57M |
2020 Q2
0 quarters
|
|
1195
American Superconductor
AMSC
$1.44B
| $10.4M | 0.01% |
1,282,317
+121,900
| +11% | +$797K |
2014 Q4
22 quarters
|
|
1196
Guardant Health
GH
$21.8B
| $10.4M | 0.01% |
+128,300
| New | +$10.3M |
2020 Q2
0 quarters
|
|
|
ECOM
1197
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $10.4M | 0.01% |
656,909
+86,700
| +15% | +$1M |
2015 Q3
19 quarters
|
|
1198
AGNC Investment
AGNC
$10.3B
| $10.4M | 0.01% |
+803,929
| New | +$10.1M |
2020 Q2
0 quarters
|
|
|
QUOT
1199
DELISTED
Quotient Technology Inc
QUOT
| $10.4M | 0.01% |
1,416,200
+172,200
| +14% | +$1.15M |
2019 Q1
5 quarters
|
|
|
PCTI
1200
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $10.4M | 0.01% |
1,549,937
+153,999
| +11% | +$984K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.